$1.9 Billion is the total value of Boxer Capital, LLC's 71 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 19.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | Buy | Prometheus Biosciences Inc | $208,725,000 | +106.4% | 1,897,500 | +10.7% | 11.00% | +93.4% |
| BGNE | BeiGene Ltdsponsored adr | $109,970,000 | +63.1% | 500,000 | 0.0% | 5.80% | +52.9% | |
| CYTK | Cytokinetics Inc | $96,222,000 | -5.4% | 2,100,000 | 0.0% | 5.07% | -11.3% | |
| RVMD | Revolution Medicines Inc | $94,905,168 | +20.8% | 3,984,264 | 0.0% | 5.00% | +13.2% | |
| MRTX | Mirati Therapeutics Inc | $90,620,000 | -35.1% | 2,000,000 | 0.0% | 4.78% | -39.2% | |
| SWTX | Springworks Therapeutics Inc | $88,994,281 | -8.8% | 3,421,541 | 0.0% | 4.69% | -14.5% | |
| APLS | Buy | Apellis Pharmaceuticals Inc | $81,494,960 | -8.5% | 1,576,000 | +20.9% | 4.30% | -14.2% |
| Amylyx Pharmaceuticals Inc | $77,003,800 | +31.3% | 2,084,000 | 0.0% | 4.06% | +23.0% | ||
| Buy | Tango Therapeutics Inc | $51,646,405 | +107.6% | 7,123,642 | +3.7% | 2.72% | +94.6% | |
| Tyra Biosciences Inc | $49,007,528 | -13.5% | 6,448,359 | 0.0% | 2.58% | -18.9% | ||
| RETA | Sell | Reata Pharmaceuticals Inccl a | $46,727,852 | +50.1% | 1,230,004 | -0.7% | 2.46% | +40.7% |
| AKRO | Akero Therapeutics Inc | $45,565,926 | +60.9% | 831,495 | 0.0% | 2.40% | +50.9% | |
| ITOS | iTeos Therapeutics Inc | $42,068,752 | +2.5% | 2,154,058 | 0.0% | 2.22% | -3.9% | |
| SAGE | Sage Therapeutics Inc | $41,725,160 | -2.6% | 1,094,000 | 0.0% | 2.20% | -8.7% | |
| ANAB | AnaptysBio Inc | $40,287,000 | +21.5% | 1,300,000 | 0.0% | 2.12% | +13.9% | |
| IDYA | Ideaya Biosciences Inc | $40,025,094 | +21.8% | 2,202,812 | 0.0% | 2.11% | +14.2% | |
| CNTA | Centessa Pharmaceuticals PLCsponsored ads | $38,785,245 | +671.1% | 1,251,137 | 0.0% | 2.04% | +622.6% | |
| Nuvalent Inc | $36,039,518 | +53.2% | 1,210,192 | 0.0% | 1.90% | +43.6% | ||
| RLAY | Relay Therapeutics Inc | $32,406,832 | -33.2% | 2,169,132 | 0.0% | 1.71% | -37.4% | |
| AXSM | New | Axsome Therapeutics Inc | $30,852,000 | – | 400,000 | +100.0% | 1.63% | – |
| RCUS | Arcus Biosciences Inc | $29,617,896 | -20.9% | 1,432,200 | 0.0% | 1.56% | -25.9% | |
| MRUS | Merus N V | $29,393,000 | -22.8% | 1,900,000 | 0.0% | 1.55% | -27.6% | |
| RCKT | Rocket Pharmaceuticals Inc | $28,690,618 | +22.6% | 1,466,051 | 0.0% | 1.51% | +14.9% | |
| FOLD | Amicus Therapeutics Inc | $28,388,250 | +17.0% | 2,325,000 | 0.0% | 1.50% | +9.7% | |
| Ventyx Biosciences Inc | $27,871,500 | -6.1% | 850,000 | 0.0% | 1.47% | -12.0% | ||
| PMVP | PMV Pharmaceuticals Inc | $27,525,016 | -26.9% | 3,163,795 | 0.0% | 1.45% | -31.5% | |
| BLU | Bellus Health Inc New | $26,304,000 | -22.2% | 3,200,000 | 0.0% | 1.39% | -27.0% | |
| DAWN | Day One Biopharmaceuticals I | $25,607,573 | +7.4% | 1,189,943 | 0.0% | 1.35% | +0.7% | |
| RNA | Avidity Biosciences Inc | $24,882,246 | +35.9% | 1,121,327 | 0.0% | 1.31% | +27.4% | |
| XENE | Xenon Pharmaceuticals Inc | $23,658,000 | +9.2% | 600,000 | 0.0% | 1.25% | +2.4% | |
| GERN | New | Geron Corp | $19,602,000 | – | 8,100,000 | +100.0% | 1.03% | – |
| EXEL | Sell | Exelixis Inc | $18,446,000 | -5.9% | 1,150,000 | -8.0% | 0.97% | -11.8% |
| PNT | Point Biopharma Global Inc | $18,225,000 | -5.7% | 2,500,000 | 0.0% | 0.96% | -11.6% | |
| PRTA | Prothena Corp PLC | $18,075,000 | -0.6% | 300,000 | 0.0% | 0.95% | -6.8% | |
| ETNB | 89Bio Inc | $17,822,000 | +119.9% | 1,400,000 | 0.0% | 0.94% | +106.1% | |
| ISEE | New | Iveric Bio Inc | $17,663,250 | – | 825,000 | +100.0% | 0.93% | – |
| RAIN | Buy | Rain Oncology Inc | $17,177,696 | +199.6% | 2,147,212 | +82.7% | 0.91% | +181.4% |
| VKTX | New | Viking Therapeutics Inc | $14,100,000 | – | 1,500,000 | +100.0% | 0.74% | – |
| NRIX | Nurix Therapeutics Inc | $13,449,314 | -15.7% | 1,224,892 | 0.0% | 0.71% | -21.0% | |
| FATE | Buy | Fate Therapeutics Inc | $12,612,500 | +60.8% | 1,250,000 | +257.1% | 0.66% | +50.8% |
| ASND | Buy | Ascendis Pharma A/Ssponsored adr | $11,602,350 | +60.5% | 95,000 | +35.7% | 0.61% | +50.4% |
| CGEM | Cullinan Oncology Inc | $11,331,565 | -17.7% | 1,074,082 | 0.0% | 0.60% | -22.9% | |
| IOVA | Sell | Iovance Biotherapeutics Inc | $9,617,800 | -48.1% | 1,505,133 | -22.2% | 0.51% | -51.4% |
| ORIC | Oric Pharmaceuticals Inc | $7,362,401 | +118.3% | 1,054,000 | 0.0% | 0.39% | +104.2% | |
| GOSS | Sell | Gossamer Bio Inc | $7,241,134 | -83.1% | 3,336,928 | -6.6% | 0.38% | -84.1% |
| PANA | Panacea Acquisition Corp II | $6,208,060 | +26.7% | 500,000 | 0.0% | 0.33% | +18.5% | |
| COGT | Buy | Cogent Biosciences Inc | $6,069,000 | -4.3% | 525,000 | +23.5% | 0.32% | -10.4% |
| BCAB | BioAtla Inc | $5,662,363 | +7.1% | 686,347 | 0.0% | 0.30% | +0.7% | |
| ARVN | New | Arvinas Inc | $5,131,500 | – | 150,000 | +100.0% | 0.27% | – |
| CABA | Cabaletta Bio Inc | $4,995,000 | +1323.1% | 540,000 | 0.0% | 0.26% | +1215.0% | |
| 2Seventy Bio Inc | $4,308,663 | -35.6% | 459,836 | 0.0% | 0.23% | -39.6% | ||
| SELB | Selecta Biosciences Inc | $3,711,001 | -31.1% | 3,284,072 | 0.0% | 0.20% | -35.3% | |
| BDTX | Black Diamond Therapeutics I | $3,626,744 | +6.5% | 2,014,858 | 0.0% | 0.19% | 0.0% | |
| KNTE | Sell | Kinnate Biopharma Inc | $3,111,000 | -82.9% | 510,000 | -66.5% | 0.16% | -84.0% |
| MIST | Milestone Pharmaceuticals In | $2,767,490 | -56.9% | 698,861 | 0.0% | 0.15% | -59.6% | |
| HSAQ | Sell | Health Sciences Acq Corp 2 | $2,495,000 | -37.0% | 250,000 | -37.5% | 0.13% | -40.8% |
| NGM | NGM Biopharmaceuticals Inc | $2,510,000 | -61.6% | 500,000 | 0.0% | 0.13% | -64.1% | |
| EQRx Inc | $2,460,000 | -50.3% | 1,000,000 | 0.0% | 0.13% | -53.2% | ||
| Third Harmonic Bio Inc | $2,452,793 | -77.3% | 570,417 | 0.0% | 0.13% | -78.8% | ||
| DBVT | Sell | DBV Technologies S Asponsored adr | $2,218,500 | -41.3% | 1,450,000 | -32.1% | 0.12% | -44.8% |
| Sell | Theseus Pharmaceuticals Inc | $2,066,700 | -60.1% | 415,000 | -53.5% | 0.11% | -62.5% | |
| VERU | Sell | Veru Inc | $1,833,744 | -93.6% | 347,300 | -86.1% | 0.10% | -94.0% |
| BCEL | Atreca Inc | $1,763,188 | -49.0% | 2,202,333 | 0.0% | 0.09% | -52.1% | |
| MREO | Mereo Biopharma Group PLCspon ads | $1,687,500 | -12.9% | 2,250,000 | 0.0% | 0.09% | -18.3% | |
| ZIOP | Alaunos Therapeutics Inc | $973,650 | -62.3% | 1,500,000 | 0.0% | 0.05% | -64.8% | |
| MEIP | MEI Pharma Inc | $709,629 | -37.0% | 2,913,091 | 0.0% | 0.04% | -41.3% | |
| TARA | Protara Therapeutics Inc | $560,728 | -9.4% | 209,227 | 0.0% | 0.03% | -14.3% | |
| New | Disc Medicine Inc | $175,500 | – | 130,000 | +100.0% | 0.01% | – | |
| Bellicum Pharmaceuticals Inc | $41,004 | -39.7% | 56,950 | 0.0% | 0.00% | -50.0% | ||
| NUVBWS | Nuvation Bio Inc*w exp 07/07/202 | $38,533 | -14.4% | 266,666 | 0.0% | 0.00% | -33.3% | |
| Surrozen Inc*w exp 08/01/203 | $4,393 | -60.1% | 66,666 | 0.0% | 0.00% | -100.0% | ||
| CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -488,157 | -100.0% | -0.02% | – |
| OMEG | Exit | OMEGA ALPHA SPACcl a | $0 | – | -200,000 | -100.0% | -0.11% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -1,300,000 | -100.0% | -0.12% | – |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -500,000 | -100.0% | -0.28% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -500,000 | -100.0% | -0.36% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -275,000 | -100.0% | -1.02% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,263,930 | -100.0% | -1.16% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -1.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.